Metraipolis › archive › dc_ec7cacffa59f

Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41178701
DOI
10.1111/dom.70267
License (as archived)
solo-consultazione
Archived
2026-11-08T19:56:21.884Z
SHA-256 of the archived text
6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea
Stable URL of this page
https://metraipolis.com/documento/dc_ec7cacffa59f

How to cite

Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701 — Europe PMC (en), https://europepmc.org/article/MED/41178701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec7cacffa59f (Metraipolis archive dc_ec7cacffa59f, sha256 6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea)
BibTeX
@misc{dcec7cacffa59f,
  title = {Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41178701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec7cacffa59f; sha256 6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41178701. Agents can read the archived copy with the MCP tool read_document.